Bened Biomedical Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

Bened Biomedical General Information

Description

Developer of microbiome-based therapeutic products designed to improve human health through beneficial bacterial applications. The company offers probiotic drug development, gut microbiome research, and bacterial strain cultivation technologies, enabling healthcare providers and individuals to address microbiome-related conditions and support digestive and neurological well-being.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8th Floor, Number 508, Section 7, Zhongxiao East Road
  • Nangang District
  • Taipei, 115
  • Taiwan
+886 02
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 8th Floor, Number 508, Section 7, Zhongxiao East Road
  • Nangang District
  • Taipei, 115
  • Taiwan
+886 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bened Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 01-Nov-2026 Completed Generating Revenue
4. Later Stage VC (Series B) Completed Generating Revenue
3. Later Stage VC (Series A) 18-Feb-2022 Completed Generating Revenue
2. Early Stage VC 01-Jan-2018 Completed Generating Revenue
1. University Spin-Out 13-Mar-2015 Completed Startup
To view Bened Biomedical’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Bened Biomedical Patents

Bened Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260144832-A1 Method for preventing or treating chronic pain Pending 27-Nov-2024
WO-2025102265-A1 Use of lacticaseibacillus bacteria for treating and/or preventing polycystic ovary syndrome Inactive 15-Nov-2023
US-20260335382-A1 Lactic acid bacterium and method for preventing or minimizing exercise-induced muscle damage Pending 24-Oct-2022
WO-2024086963-A1 Lactic acid bacterium and method for preventing or minimizing exercise-induced muscle damage Inactive 24-Oct-2022
WO-2024060118-A1 Method for treating sleeping disorders with groel protein Inactive 22-Sep-2022 A61P3/00
To view Bened Biomedical’s complete patent history, request access »

Bened Biomedical Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Maxpro Ventures Venture Capital Minority
JIF Capital Venture Capital Minority
Trans-Pacific Technology Fund Venture Capital Minority
B Current Impact Investment Venture Capital Minority
National Yang Ming Chiao Tung University Corporation Minority
To view Bened Biomedical’s complete investors history, request access »

Bened Biomedical Acquisitions (1)

Bened Biomedical’s most recent deal was a Merger/Acquisition with Oryx Biomedical. The deal was made on 01-Jun-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Oryx Biomedical 01-Jun-2022 Merger/Acquisition Other Pharmaceuticals and Biotechnology
To view Bened Biomedical’s complete acquisitions history, request access »

Bened Biomedical FAQs

  • When was Bened Biomedical founded?

    Bened Biomedical was founded in 2015.

  • Where is Bened Biomedical headquartered?

    Bened Biomedical is headquartered in Taipei, Taiwan.

  • What industry is Bened Biomedical in?

    Bened Biomedical’s primary industry is Drug Discovery.

  • Is Bened Biomedical a private or public company?

    Bened Biomedical is a Private company.

  • What is Bened Biomedical’s current revenue?

    The current revenue for Bened Biomedical is .

  • How much funding has Bened Biomedical raised over time?

    Bened Biomedical has raised $10M.

  • Who are Bened Biomedical’s investors?

    Maxpro Ventures, JIF Capital, Trans-Pacific Technology Fund, B Current Impact Investment, and National Yang Ming Chiao Tung University have invested in Bened Biomedical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process